APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti Influenza Virus Chinese Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti Influenza Virus Chinese Medicine Industry Growth and Trends Forecast to 2032

2 January 2026129 pages

Choose your research edition.

Industry ResearchAnti Influenza Virus Chinese Medicine Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti Influenza Virus Chinese Medicine Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Anti Influenza Virus Chinese Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti Influenza Virus Chinese Medicine Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti Influenza Virus Chinese Medicine Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Anti Influenza Virus Chinese Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti Influenza Virus Chinese Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti Influenza Virus Chinese Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti Influenza Virus Chinese Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti Influenza Virus Chinese Medicine include China TCM, ZBD Pharmaceutical, Zhejiang Kanglaite Pharmaceutical, Zhejiang Conba Pharmaceutical, Changbaishan Pharmaceutical, Yunnan Baiyao, Yiling Pharmaceutical, Wuzhou Pharmaceutical and Tongrentang, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti Influenza Virus Chinese Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti Influenza Virus Chinese Medicine market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti Influenza Virus Chinese Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti Influenza Virus Chinese Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti Influenza Virus Chinese Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti Influenza Virus Chinese Medicine Market by Company

China TCM

ZBD Pharmaceutical

Zhejiang Kanglaite Pharmaceutical

Zhejiang Conba Pharmaceutical

Changbaishan Pharmaceutical

Yunnan Baiyao

Yiling Pharmaceutical

Wuzhou Pharmaceutical

Tongrentang

Yusheng Pharmaceutical

TASLY

Chase Sun Pharmaceutical

Green Valley Pharma

Livzon

Qingfeng Pharmaceutical Group

Jumpcan

CR SANJIU

Gerun Pharmaceutical

Fusen Pharmaceutical

Shineway Pharmaceutical

Harbin Pharmaceutical Group

Harbin Pharmaceutical Group

Guangzhou Pharmaceutical

Buchang Pharmaceutical

Anti Influenza Virus Chinese Medicine Segment by Type

Injection

Syrup

Aerosol

Oral Solution

Particles

Chewable Tablets

Capsule

Lozenges

Pills

Anti Influenza Virus Chinese Medicine Segment by Application

Adult

Children

Anti Influenza Virus Chinese Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti Influenza Virus Chinese Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti Influenza Virus Chinese Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti Influenza Virus Chinese Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti Influenza Virus Chinese Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti Influenza Virus Chinese Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Syrup Table 3. Major Company of Aerosol Table 4. Major Company of Oral Solution Table 5. Major Company of Particles Table 6. Major Company of Chewable Tablets Table 7. Major Company of Capsule Table 8. Major Company of Lozenges Table 9. Major Company of Pills Table 10. Global Anti Influenza Virus Chinese Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 11. Global Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Tons) Table 12. Global Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Type (2021-2026) Table 13. Global Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (US$ Million) Table 14. Global Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Type (2021-2026) Table 15. Global Anti Influenza Virus Chinese Medicine Price by Type (2021-2026) & (US$/Ton) Table 16. Global Anti Influenza Virus Chinese Medicine Sales by Type (2027-2032) & (K Tons) Table 17. Global Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Type (2027-2032) Table 18. Global Anti Influenza Virus Chinese Medicine Sales by Type (2027-2032) & (US$ Million) Table 19. Global Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Type (2027-2032) Table 20. Global Anti Influenza Virus Chinese Medicine Price by Type (2027-2032) & (US$/Ton) Table 21. North America Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Tons) Table 22. North America Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (US$ Million) Table 23. Europe Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Tons) Table 24. Europe Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (US$ Million) Table 25. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Tons) Table 26. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (US$ Million) Table 27. Latin America Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Tons) Table 28. Latin America Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (US$ Million) Table 29. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Tons) Table 30. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (US$ Million) Table 31. Anti Influenza Virus Chinese Medicine Industry Trends Table 32. Anti Influenza Virus Chinese Medicine Industry Drivers Table 33. Anti Influenza Virus Chinese Medicine Industry Opportunities and Challenges Table 34. Anti Influenza Virus Chinese Medicine Industry Restraints Table 35. Global Anti Influenza Virus Chinese Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 36. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Company (2021-2026) Table 37. Global Anti Influenza Virus Chinese Medicine Sales by Company (2021-2026) & (K Tons) Table 38. Global Anti Influenza Virus Chinese Medicine Sales Share by Company (2021-2026) Table 39. Global Anti Influenza Virus Chinese Medicine Market Price by Company (2021-2026) & (US$/Ton) Table 40. Global Anti Influenza Virus Chinese Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 41. Global Anti Influenza Virus Chinese Medicine Major Company Production Sites and Headquarters Table 42. Global Anti Influenza Virus Chinese Medicine Company, Product Type & Application Table 43. Global Anti Influenza Virus Chinese Medicine Company Establishment Date Table 44. Global Company Market Concentration Ratio (CR5 and HHI) Table 45. Global Anti Influenza Virus Chinese Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 46. Global Anti Influenza Virus Chinese Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 47. Global Anti Influenza Virus Chinese Medicine Sales by Region (2021-2026) & (K Tons) Table 48. Global Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Region (2021-2026) Table 49. Global Anti Influenza Virus Chinese Medicine Sales by Region (2021-2026) & (US$ Million) Table 50. Global Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Region (2021-2026) Table 51. Global Anti Influenza Virus Chinese Medicine Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 52. Global Anti Influenza Virus Chinese Medicine Sales by Region (2027-2032) & (K Tons) Table 53. Global Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Region (2027-2032) Table 54. Global Anti Influenza Virus Chinese Medicine Sales by Region (2027-2032) & (US$ Million) Table 55. Global Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Region (2027-2032) Table 56. Global Anti Influenza Virus Chinese Medicine Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 57. Global Anti Influenza Virus Chinese Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 58. Global Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Tons) Table 59. Global Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Application (2021-2026) Table 60. Global Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (US$ Million) Table 61. Global Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Application (2021-2026) Table 62. Global Anti Influenza Virus Chinese Medicine Price by Application (2021-2026) & (US$/Ton) Table 63. Global Anti Influenza Virus Chinese Medicine Sales by Application (2027-2032) & (K Tons) Table 64. Global Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Application (2027-2032) Table 65. Global Anti Influenza Virus Chinese Medicine Sales by Application (2027-2032) & (US$ Million) Table 66. Global Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Application (2027-2032) Table 67. Global Anti Influenza Virus Chinese Medicine Price by Application (2027-2032) & (US$/Ton) Table 68. North America Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Tons) Table 69. North America Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (US$ Million) Table 70. Europe Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Tons) Table 71. Europe Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (US$ Million) Table 72. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Tons) Table 73. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (US$ Million) Table 74. Latin America Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Tons) Table 75. Latin America Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (US$ Million) Table 76. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Tons) Table 77. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (US$ Million) Table 78. China TCM Company Information Table 79. China TCM Business Overview Table 80. China TCM Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. China TCM Anti Influenza Virus Chinese Medicine Product Portfolio Table 82. China TCM Recent Development Table 83. ZBD Pharmaceutical Company Information Table 84. ZBD Pharmaceutical Business Overview Table 85. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 87. ZBD Pharmaceutical Recent Development Table 88. Zhejiang Kanglaite Pharmaceutical Company Information Table 89. Zhejiang Kanglaite Pharmaceutical Business Overview Table 90. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 92. Zhejiang Kanglaite Pharmaceutical Recent Development Table 93. Zhejiang Conba Pharmaceutical Company Information Table 94. Zhejiang Conba Pharmaceutical Business Overview Table 95. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 97. Zhejiang Conba Pharmaceutical Recent Development Table 98. Changbaishan Pharmaceutical Company Information Table 99. Changbaishan Pharmaceutical Business Overview Table 100. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 102. Changbaishan Pharmaceutical Recent Development Table 103. Yunnan Baiyao Company Information Table 104. Yunnan Baiyao Business Overview Table 105. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product Portfolio Table 107. Yunnan Baiyao Recent Development Table 108. Yiling Pharmaceutical Company Information Table 109. Yiling Pharmaceutical Business Overview Table 110. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 112. Yiling Pharmaceutical Recent Development Table 113. Wuzhou Pharmaceutical Company Information Table 114. Wuzhou Pharmaceutical Business Overview Table 115. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 117. Wuzhou Pharmaceutical Recent Development Table 118. Tongrentang Company Information Table 119. Tongrentang Business Overview Table 120. Tongrentang Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Tongrentang Anti Influenza Virus Chinese Medicine Product Portfolio Table 122. Tongrentang Recent Development Table 123. Yusheng Pharmaceutical Company Information Table 124. Yusheng Pharmaceutical Business Overview Table 125. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 127. Yusheng Pharmaceutical Recent Development Table 128. TASLY Company Information Table 129. TASLY Business Overview Table 130. TASLY Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. TASLY Anti Influenza Virus Chinese Medicine Product Portfolio Table 132. TASLY Recent Development Table 133. Chase Sun Pharmaceutical Company Information Table 134. Chase Sun Pharmaceutical Business Overview Table 135. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 137. Chase Sun Pharmaceutical Recent Development Table 138. Green Valley Pharma Company Information Table 139. Green Valley Pharma Business Overview Table 140. Green Valley Pharma Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 141. Green Valley Pharma Anti Influenza Virus Chinese Medicine Product Portfolio Table 142. Green Valley Pharma Recent Development Table 143. Livzon Company Information Table 144. Livzon Business Overview Table 145. Livzon Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 146. Livzon Anti Influenza Virus Chinese Medicine Product Portfolio Table 147. Livzon Recent Development Table 148. Qingfeng Pharmaceutical Group Company Information Table 149. Qingfeng Pharmaceutical Group Business Overview Table 150. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 151. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio Table 152. Qingfeng Pharmaceutical Group Recent Development Table 153. Jumpcan Company Information Table 154. Jumpcan Business Overview Table 155. Jumpcan Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 156. Jumpcan Anti Influenza Virus Chinese Medicine Product Portfolio Table 157. Jumpcan Recent Development Table 158. CR SANJIU Company Information Table 159. CR SANJIU Business Overview Table 160. CR SANJIU Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 161. CR SANJIU Anti Influenza Virus Chinese Medicine Product Portfolio Table 162. CR SANJIU Recent Development Table 163. Gerun Pharmaceutical Company Information Table 164. Gerun Pharmaceutical Business Overview Table 165. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 166. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 167. Gerun Pharmaceutical Recent Development Table 168. Fusen Pharmaceutical Company Information Table 169. Fusen Pharmaceutical Business Overview Table 170. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 171. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 172. Fusen Pharmaceutical Recent Development Table 173. Shineway Pharmaceutical Company Information Table 174. Shineway Pharmaceutical Business Overview Table 175. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 176. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 177. Shineway Pharmaceutical Recent Development Table 178. Harbin Pharmaceutical Group Company Information Table 179. Harbin Pharmaceutical Group Business Overview Table 180. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 181. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio Table 182. Harbin Pharmaceutical Group Recent Development Table 183. Harbin Pharmaceutical Group Company Information Table 184. Harbin Pharmaceutical Group Business Overview Table 185. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 186. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio Table 187. Harbin Pharmaceutical Group Recent Development Table 188. Guangzhou Pharmaceutical Company Information Table 189. Guangzhou Pharmaceutical Business Overview Table 190. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 191. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 192. Guangzhou Pharmaceutical Recent Development Table 193. Buchang Pharmaceutical Company Information Table 194. Buchang Pharmaceutical Business Overview Table 195. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 196. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio Table 197. Buchang Pharmaceutical Recent Development Table 198. North America Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 199. North America Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 200. North America Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2021-2026) Table 201. North America Anti Influenza Virus Chinese Medicine Sales Forecast by Country (2027-2032) & (K Tons) Table 202. North America Anti Influenza Virus Chinese Medicine Sales Market Share Forecast by Country (2027-2032) Table 203. North America Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. North America Anti Influenza Virus Chinese Medicine Market Size by Country (2021-2026) & (US$ Million) Table 205. North America Anti Influenza Virus Chinese Medicine Market Share by Country (2021-2026) Table 206. North America Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. North America Anti Influenza Virus Chinese Medicine Market Share Forecast by Country (2027-2032) Table 208. Europe Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 209. Europe Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 210. Europe Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2021-2026) Table 211. Europe Anti Influenza Virus Chinese Medicine Sales Forecast by Country (2027-2032) & (K Tons) Table 212. Europe Anti Influenza Virus Chinese Medicine Sales Market Share Forecast by Country (2027-2032) Table 213. Europe Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 214. Europe Anti Influenza Virus Chinese Medicine Market Size by Country (2021-2026) & (US$ Million) Table 215. Europe Anti Influenza Virus Chinese Medicine Market Share by Country (2021-2026) Table 216. Europe Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 217. Europe Anti Influenza Virus Chinese Medicine Market Share Forecast by Country (2027-2032) Table 218. Asia-Pacific Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 219. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 220. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2021-2026) Table 221. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Forecast by Country (2027-2032) & (K Tons) Table 222. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Market Share Forecast by Country (2027-2032) Table 223. Asia-Pacific Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 224. Asia-Pacific Anti Influenza Virus Chinese Medicine Market Size by Country (2021-2026) & (US$ Million) Table 225. Asia-Pacific Anti Influenza Virus Chinese Medicine Market Share by Country (2021-2026) Table 226. Asia-Pacific Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 227. Asia-Pacific Anti Influenza Virus Chinese Medicine Market Share Forecast by Country (2027-2032) Table 228. Latin America Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 229. Latin America Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 230. Latin America Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2021-2026) Table 231. Latin America Anti Influenza Virus Chinese Medicine Sales Forecast by Country (2027-2032) & (K Tons) Table 232. Latin America Anti Influenza Virus Chinese Medicine Sales Market Share Forecast by Country (2027-2032) Table 233. Latin America Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 234. Latin America Anti Influenza Virus Chinese Medicine Market Size by Country (2021-2026) & (US$ Million) Table 235. Latin America Anti Influenza Virus Chinese Medicine Market Share by Country (2021-2026) Table 236. Latin America Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 237. Latin America Anti Influenza Virus Chinese Medicine Market Share Forecast by Country (2027-2032) Table 238. Middle East and Africa Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 239. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Tons) Table 240. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2021-2026) Table 241. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Forecast by Country (2027-2032) & (K Tons) Table 242. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Market Share Forecast by Country (2027-2032) Table 243. Middle East and Africa Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 244. Middle East and Africa Anti Influenza Virus Chinese Medicine Market Size by Country (2021-2026) & (US$ Million) Table 245. Middle East and Africa Anti Influenza Virus Chinese Medicine Market Share by Country (2021-2026) Table 246. Middle East and Africa Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 247. Middle East and Africa Anti Influenza Virus Chinese Medicine Market Share Forecast by Country (2027-2032) Table 248. Key Raw Materials Table 249. Raw Materials Key Suppliers Table 250. Anti Influenza Virus Chinese Medicine Distributors List Table 251. Anti Influenza Virus Chinese Medicine Customers List Table 252. Research Programs/Design for This Report Table 253. Authors List of This Report Table 254. Secondary Sources Table 255. Primary Sources List of Figures Figure 1. Anti Influenza Virus Chinese Medicine Image Figure 2. Global Anti Influenza Virus Chinese Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti Influenza Virus Chinese Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti Influenza Virus Chinese Medicine Sales (2021-2032) & (K Tons) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (K Tons) Figure 7. Syrup Image Figure 8. Global Syrup Sales YoY Growth (2021-2032) & (K Tons) Figure 9. Aerosol Image Figure 10. Global Aerosol Sales YoY Growth (2021-2032) & (K Tons) Figure 11. Oral Solution Image Figure 12. Global Oral Solution Sales YoY Growth (2021-2032) & (K Tons) Figure 13. Particles Image Figure 14. Global Particles Sales YoY Growth (2021-2032) & (K Tons) Figure 15. Chewable Tablets Image Figure 16. Global Chewable Tablets Sales YoY Growth (2021-2032) & (K Tons) Figure 17. Capsule Image Figure 18. Global Capsule Sales YoY Growth (2021-2032) & (K Tons) Figure 19. Lozenges Image Figure 20. Global Lozenges Sales YoY Growth (2021-2032) & (K Tons) Figure 21. Pills Image Figure 22. Global Pills Sales YoY Growth (2021-2032) & (K Tons) Figure 23. Global Anti Influenza Virus Chinese Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 24. Global Anti Influenza Virus Chinese Medicine Market Share by Type 2025 VS 2032 Figure 25. North America Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Type in 2025 Figure 26. North America Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Type in 2025 Figure 27. Europe Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Type in 2025 Figure 28. Europe Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Type in 2025 Figure 29. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Type in 2025 Figure 30. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Type in 2025 Figure 31. Latin America Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Type in 2025 Figure 32. Latin America Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Type in 2025 Figure 33. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Type in 2025 Figure 34. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Type in 2025 Figure 35. Global Top 5 and 10 Anti Influenza Virus Chinese Medicine Players Market Share by Revenue in 2025 Figure 36. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 37. Adult Image Figure 38. Global Adult Sales YoY Growth (2021-2032) & (K Tons) Figure 39. Children Image Figure 40. Global Children Sales YoY Growth (2021-2032) & (K Tons) Figure 41. Global Anti Influenza Virus Chinese Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Anti Influenza Virus Chinese Medicine Market Share by Application 2025 VS 2032 Figure 43. North America Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Application in 2025 Figure 44. North America Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Application in 2025 Figure 45. Europe Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Application in 2025 Figure 46. Europe Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Application in 2025 Figure 49. Latin America Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Market Share in Value by Application in 2025 Figure 53. North America Anti Influenza Virus Chinese Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 54. North America Anti Influenza Virus Chinese Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Anti Influenza Virus Chinese Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Anti Influenza Virus Chinese Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Anti Influenza Virus Chinese Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 58. Europe Anti Influenza Virus Chinese Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Anti Influenza Virus Chinese Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Anti Influenza Virus Chinese Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 62. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Anti Influenza Virus Chinese Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Anti Influenza Virus Chinese Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Anti Influenza Virus Chinese Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 66. Latin America Anti Influenza Virus Chinese Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Anti Influenza Virus Chinese Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Anti Influenza Virus Chinese Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 70. Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Anti Influenza Virus Chinese Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Anti Influenza Virus Chinese Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Anti Influenza Virus Chinese Medicine Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Anti Influenza Virus Chinese Medicine Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Syrup
  • Aerosol
  • Oral Solution
  • Particles
  • Chewable Tablets
  • Capsule
  • Lozenges
  • Pills
Applications
  • Adult
  • Children
Companies covered
  • China TCM
  • ZBD Pharmaceutical
  • Zhejiang Kanglaite Pharmaceutical
  • Zhejiang Conba Pharmaceutical
  • Changbaishan Pharmaceutical
  • Yunnan Baiyao
  • Yiling Pharmaceutical
  • Wuzhou Pharmaceutical
  • Tongrentang
  • Yusheng Pharmaceutical
  • TASLY
  • Chase Sun Pharmaceutical
  • Green Valley Pharma
  • Livzon
  • Qingfeng Pharmaceutical Group
  • Jumpcan
  • CR SANJIU
  • Gerun Pharmaceutical
  • Fusen Pharmaceutical
  • Shineway Pharmaceutical
  • Harbin Pharmaceutical Group
  • Harbin Pharmaceutical Group
  • Guangzhou Pharmaceutical
  • Buchang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti Influenza Virus Chinese Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti Influenza Virus Chinese Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti Influenza Virus Chinese Medicine Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Syrup
  8. 1.3.3 Aerosol
  9. 1.3.4 Oral Solution
  10. 1.3.5 Particles
  11. 1.3.6 Chewable Tablets
  12. 1.3.7 Capsule
  13. 1.3.8 Lozenges
  14. 1.3.9 Pills
  15. 1.4 Global Anti Influenza Virus Chinese Medicine Market Size by Type
  16. 1.4.1 Global Anti Influenza Virus Chinese Medicine Market Size Overview by Type (2021-2032)
  17. 1.4.2 Global Anti Influenza Virus Chinese Medicine Historic Market Size Review by Type (2021-2026)
  18. 1.4.3 Global Anti Influenza Virus Chinese Medicine Forecasted Market Size by Type (2027-2032)
  19. 1.5 Key Regions Market Size by Type
  20. 1.5.1 North America Anti Influenza Virus Chinese Medicine Sales Breakdown by Type (2021-2026)
  21. 1.5.2 Europe Anti Influenza Virus Chinese Medicine Sales Breakdown by Type (2021-2026)
  22. 1.5.3 Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Breakdown by Type (2021-2026)
  23. 1.5.4 South America Anti Influenza Virus Chinese Medicine Sales Breakdown by Type (2021-2026)
  24. 1.5.5 Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti Influenza Virus Chinese Medicine Industry Trends
  2. 2.2 Anti Influenza Virus Chinese Medicine Industry Drivers
  3. 2.3 Anti Influenza Virus Chinese Medicine Industry Opportunities and Challenges
  4. 2.4 Anti Influenza Virus Chinese Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti Influenza Virus Chinese Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti Influenza Virus Chinese Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Anti Influenza Virus Chinese Medicine Price (2021-2026)
  4. 3.4 Global Anti Influenza Virus Chinese Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti Influenza Virus Chinese Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Anti Influenza Virus Chinese Medicine Company, Product Type & Application
  7. 3.7 Global Anti Influenza Virus Chinese Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti Influenza Virus Chinese Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti Influenza Virus Chinese Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti Influenza Virus Chinese Medicine Tier 1, Tier 2, and Tier 3
4 Anti Influenza Virus Chinese Medicine Regional Status and Outlook
  1. 4.1 Global Anti Influenza Virus Chinese Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti Influenza Virus Chinese Medicine Historic Market Size by Region
  3. 4.2.1 Global Anti Influenza Virus Chinese Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti Influenza Virus Chinese Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti Influenza Virus Chinese Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti Influenza Virus Chinese Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Anti Influenza Virus Chinese Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti Influenza Virus Chinese Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti Influenza Virus Chinese Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti Influenza Virus Chinese Medicine by Application
  1. 5.1 Anti Influenza Virus Chinese Medicine Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Anti Influenza Virus Chinese Medicine Market Size by Application
  5. 5.2.1 Global Anti Influenza Virus Chinese Medicine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Anti Influenza Virus Chinese Medicine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Anti Influenza Virus Chinese Medicine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Anti Influenza Virus Chinese Medicine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Anti Influenza Virus Chinese Medicine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Anti Influenza Virus Chinese Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 China TCM
  2. 6.1.1 China TCM Company Information
  3. 6.1.2 China TCM Business Overview
  4. 6.1.3 China TCM Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 China TCM Anti Influenza Virus Chinese Medicine Product Portfolio
  6. 6.1.5 China TCM Recent Developments
  7. 6.2 ZBD Pharmaceutical
  8. 6.2.1 ZBD Pharmaceutical Company Information
  9. 6.2.2 ZBD Pharmaceutical Business Overview
  10. 6.2.3 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  12. 6.2.5 ZBD Pharmaceutical Recent Developments
  13. 6.3 Zhejiang Kanglaite Pharmaceutical
  14. 6.3.1 Zhejiang Kanglaite Pharmaceutical Company Information
  15. 6.3.2 Zhejiang Kanglaite Pharmaceutical Business Overview
  16. 6.3.3 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  18. 6.3.5 Zhejiang Kanglaite Pharmaceutical Recent Developments
  19. 6.4 Zhejiang Conba Pharmaceutical
  20. 6.4.1 Zhejiang Conba Pharmaceutical Company Information
  21. 6.4.2 Zhejiang Conba Pharmaceutical Business Overview
  22. 6.4.3 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  24. 6.4.5 Zhejiang Conba Pharmaceutical Recent Developments
  25. 6.5 Changbaishan Pharmaceutical
  26. 6.5.1 Changbaishan Pharmaceutical Company Information
  27. 6.5.2 Changbaishan Pharmaceutical Business Overview
  28. 6.5.3 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  30. 6.5.5 Changbaishan Pharmaceutical Recent Developments
  31. 6.6 Yunnan Baiyao
  32. 6.6.1 Yunnan Baiyao Company Information
  33. 6.6.2 Yunnan Baiyao Business Overview
  34. 6.6.3 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product Portfolio
  36. 6.6.5 Yunnan Baiyao Recent Developments
  37. 6.7 Yiling Pharmaceutical
  38. 6.7.1 Yiling Pharmaceutical Company Information
  39. 6.7.2 Yiling Pharmaceutical Business Overview
  40. 6.7.3 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  42. 6.7.5 Yiling Pharmaceutical Recent Developments
  43. 6.8 Wuzhou Pharmaceutical
  44. 6.8.1 Wuzhou Pharmaceutical Company Information
  45. 6.8.2 Wuzhou Pharmaceutical Business Overview
  46. 6.8.3 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  48. 6.8.5 Wuzhou Pharmaceutical Recent Developments
  49. 6.9 Tongrentang
  50. 6.9.1 Tongrentang Company Information
  51. 6.9.2 Tongrentang Business Overview
  52. 6.9.3 Tongrentang Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Tongrentang Anti Influenza Virus Chinese Medicine Product Portfolio
  54. 6.9.5 Tongrentang Recent Developments
  55. 6.10 Yusheng Pharmaceutical
  56. 6.10.1 Yusheng Pharmaceutical Company Information
  57. 6.10.2 Yusheng Pharmaceutical Business Overview
  58. 6.10.3 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  60. 6.10.5 Yusheng Pharmaceutical Recent Developments
  61. 6.11 TASLY
  62. 6.11.1 TASLY Company Information
  63. 6.11.2 TASLY Business Overview
  64. 6.11.3 TASLY Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 TASLY Anti Influenza Virus Chinese Medicine Product Portfolio
  66. 6.11.5 TASLY Recent Developments
  67. 6.12 Chase Sun Pharmaceutical
  68. 6.12.1 Chase Sun Pharmaceutical Company Information
  69. 6.12.2 Chase Sun Pharmaceutical Business Overview
  70. 6.12.3 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  72. 6.12.5 Chase Sun Pharmaceutical Recent Developments
  73. 6.13 Green Valley Pharma
  74. 6.13.1 Green Valley Pharma Company Information
  75. 6.13.2 Green Valley Pharma Business Overview
  76. 6.13.3 Green Valley Pharma Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Green Valley Pharma Anti Influenza Virus Chinese Medicine Product Portfolio
  78. 6.13.5 Green Valley Pharma Recent Developments
  79. 6.14 Livzon
  80. 6.14.1 Livzon Company Information
  81. 6.14.2 Livzon Business Overview
  82. 6.14.3 Livzon Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Livzon Anti Influenza Virus Chinese Medicine Product Portfolio
  84. 6.14.5 Livzon Recent Developments
  85. 6.15 Qingfeng Pharmaceutical Group
  86. 6.15.1 Qingfeng Pharmaceutical Group Company Information
  87. 6.15.2 Qingfeng Pharmaceutical Group Business Overview
  88. 6.15.3 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio
  90. 6.15.5 Qingfeng Pharmaceutical Group Recent Developments
  91. 6.16 Jumpcan
  92. 6.16.1 Jumpcan Company Information
  93. 6.16.2 Jumpcan Business Overview
  94. 6.16.3 Jumpcan Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Jumpcan Anti Influenza Virus Chinese Medicine Product Portfolio
  96. 6.16.5 Jumpcan Recent Developments
  97. 6.17 CR SANJIU
  98. 6.17.1 CR SANJIU Company Information
  99. 6.17.2 CR SANJIU Business Overview
  100. 6.17.3 CR SANJIU Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 CR SANJIU Anti Influenza Virus Chinese Medicine Product Portfolio
  102. 6.17.5 CR SANJIU Recent Developments
  103. 6.18 Gerun Pharmaceutical
  104. 6.18.1 Gerun Pharmaceutical Company Information
  105. 6.18.2 Gerun Pharmaceutical Business Overview
  106. 6.18.3 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  108. 6.18.5 Gerun Pharmaceutical Recent Developments
  109. 6.19 Fusen Pharmaceutical
  110. 6.19.1 Fusen Pharmaceutical Company Information
  111. 6.19.2 Fusen Pharmaceutical Business Overview
  112. 6.19.3 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  114. 6.19.5 Fusen Pharmaceutical Recent Developments
  115. 6.20 Shineway Pharmaceutical
  116. 6.20.1 Shineway Pharmaceutical Company Information
  117. 6.20.2 Shineway Pharmaceutical Business Overview
  118. 6.20.3 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  120. 6.20.5 Shineway Pharmaceutical Recent Developments
  121. 6.21 Harbin Pharmaceutical Group
  122. 6.21.1 Harbin Pharmaceutical Group Company Information
  123. 6.21.2 Harbin Pharmaceutical Group Business Overview
  124. 6.21.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio
  126. 6.21.5 Harbin Pharmaceutical Group Recent Developments
  127. 6.22 Harbin Pharmaceutical Group
  128. 6.22.1 Harbin Pharmaceutical Group Company Information
  129. 6.22.2 Harbin Pharmaceutical Group Business Overview
  130. 6.22.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product Portfolio
  132. 6.22.5 Harbin Pharmaceutical Group Recent Developments
  133. 6.23 Guangzhou Pharmaceutical
  134. 6.23.1 Guangzhou Pharmaceutical Company Information
  135. 6.23.2 Guangzhou Pharmaceutical Business Overview
  136. 6.23.3 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  138. 6.23.5 Guangzhou Pharmaceutical Recent Developments
  139. 6.24 Buchang Pharmaceutical
  140. 6.24.1 Buchang Pharmaceutical Company Information
  141. 6.24.2 Buchang Pharmaceutical Business Overview
  142. 6.24.3 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product Portfolio
  144. 6.24.5 Buchang Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Anti Influenza Virus Chinese Medicine Sales by Country
  2. 7.1.1 North America Anti Influenza Virus Chinese Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Anti Influenza Virus Chinese Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti Influenza Virus Chinese Medicine Market Size by Country
  6. 7.2.1 North America Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti Influenza Virus Chinese Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti Influenza Virus Chinese Medicine Sales by Country
  2. 8.1.1 Europe Anti Influenza Virus Chinese Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti Influenza Virus Chinese Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti Influenza Virus Chinese Medicine Market Size by Country
  6. 8.2.1 Europe Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti Influenza Virus Chinese Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti Influenza Virus Chinese Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti Influenza Virus Chinese Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti Influenza Virus Chinese Medicine Sales by Country
  2. 10.1.1 South America Anti Influenza Virus Chinese Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Anti Influenza Virus Chinese Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti Influenza Virus Chinese Medicine Market Size by Country
  6. 10.2.1 South America Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti Influenza Virus Chinese Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti Influenza Virus Chinese Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti Influenza Virus Chinese Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Anti Influenza Virus Chinese Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti Influenza Virus Chinese Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti Influenza Virus Chinese Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti Influenza Virus Chinese Medicine Value Chain Analysis
  2. 12.1.1 Anti Influenza Virus Chinese Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti Influenza Virus Chinese Medicine Production Mode & Process
  7. 12.2 Anti Influenza Virus Chinese Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti Influenza Virus Chinese Medicine Distributors
  10. 12.2.3 Anti Influenza Virus Chinese Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst